Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 2;8(8):e71583.
doi: 10.1371/journal.pone.0071583. Print 2013.

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

Monica Franciosi  1 , Giuseppe Lucisano, Emanuela Lapice, Giovanni F M Strippoli, Fabio Pellegrini, Antonio Nicolucci
Affiliations

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

Monica Franciosi et al. PLoS One. .

Abstract

Aims/hypothesis: Diabetes treatments were related with either an increased or reduced risk of cancer. There is ongoing debate about a potential protective action of metformin. To summarize evidence on the association between metformin and risk of cancer and cancer mortality in patients with diabetes.

Data source: MEDLINE and EMBASE (January 1966-April 2012). We selected randomized studies comparing metformin and other hypoglycaemic agents and observational studies exploring the association between exposure to metformin and cancer. Outcomes were cancer mortality, all malignancies and site-specific cancers.

Results: Of 25307 citations identified, 12 randomized controlled trials (21,595 patients) and 41 observational studies (1,029,389 patients) met the inclusion criteria. In observational studies there was a significant association of exposure to metformin with the risk of cancer death [6 studies, 24,410 patients, OR:0.65, 95%CI: 0.53-0.80], all malignancies [18 studies, 561,836 patients, OR:0.73, 95%CI: 0.61-0.88], liver [8 studies, 312,742 patients, OR:0.34; 95%CI: 0.19-0.60] colorectal [12 studies, 871,365 patients, OR:0.83, 95%CI: 0.74-0.92], pancreas [9 studies, 847,248 patients, OR:0.56, 95%CI: 0.36-0.86], stomach [2 studies, 100701 patients, OR:0.83, 95%CI: 0.76-0.91], and esophagus cancer [2 studies, 100694 patients, OR:0.90, 95%CI: 0.83-0.98]. No significant difference of risk was observed in randomized trials. Metformin was not associated with the risk of: breast cancer, lung cancer, ovarian cancer, uterus cancer, prostate cancer, bladder cancer, kidney cancer, and melanoma.

Conclusions/interpretation: Results suggest that Metformin might be associated with a significant reduction in the risk of cancer and cancer-related mortality. Randomized trials specifically designed to evaluate the efficacy of metformin as an anticancer agent are warranted.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow-chart of the study.
Figure 2
Figure 2. (A) Mortality for Cancer. (B) All Malignancy.
Figure 3
Figure 3. (A) Liver Cancer. (B) Colorectal cancer.
Figure 4
Figure 4. (A) Pancreatic cancer. (B) Stomach Cancer.
See this image and copyright information in PMC

References

    1. Nicolucci A (2010) Epidemiological aspects of neoplasms in diabetes. Acta Diabetol 47: 87-95. doi:10.1007/s00592-010-0187-3. PubMed: 20376506. - DOI - PubMed
    1. Will JC, Vinicor F, Calle EE (1999) Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 10: 313-318. doi:10.1097/00001648-199905000-00018. PubMed: 10230844. - DOI - PubMed
    1. Chow WH, Gridley G, Nyrén O, Linet MS, Ekbom A et al. (1995) Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 87: 930-931. doi:http://dx.doi.org/10.1093/jnci/87.12.930. PubMed: 7666483. - DOI - PubMed
    1. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA et al. (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Ins 91: 542-547. doi:10.1093/jnci/91.6.542. PubMed: 10088625. - DOI - PubMed
    1. Adami HO, Chow WH, Nyrén O, Berne C, Linet MS et al. (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88: 1472-1477. doi:10.1093/jnci/88.20.1472. PubMed: 8841022. - DOI - PubMed

Publication types

MeSH terms